Professor receives prestigious 'Texty' award for textbook excellence

Patricia Tille recognized for contributions to "Bailey & Scott's Diagnostic Microbiology"


Patricia Tille, PhD. Photo/University of Cincinnati.

Patricia Tille, PhD, a faculty member at the University of Cincinnati's College of Allied Health Sciences, has been recognized with the Academic Authors Association (TAA) Textbook Excellence "Texty" Award for her outstanding contributions to clinical microbiology education.

Tille, who serves as the graduate program director in the Clinical Health and Information Sciences Department, has played a pivotal role in developing and updating the textbook "Bailey & Scott's Diagnostic Microbiology." This textbook is recognized as an impactful resource for clinical laboratory science education programs and practicing professionals worldwide.

Her commitment to maintaining the textbook's quality and relevance is commendable. Tille continuously collects and updates information to ensure the textbook reflects the latest developments in the field. This dedication has earned her the respect and admiration of her peers and the TAA Textbook Excellence Award.

In addition to her work on "Bailey & Scott's Diagnostic Microbiology," Tille has contributed chapters to other textbooks and remains actively involved in advancing the field of clinical microbiology. Her passion for education and research is evident in her work, inspiring students and colleagues alike.

Tille's recognition with the Textbook Excellence Award is a testament to her dedication and expertise in clinical microbiology. Her work has had a profound impact on the education of future laboratory professionals and underscores the importance of high-quality educational resources in advancing the field globally.

Featured image at top of "Bailey & Scott's Diagnostic Microbiology" textbook. Photo provided.

Related Stories


A new treatment for rare muscular disease

April 16, 2021

Hani Kushlaf, MD, presented findings on a new treatment for Pompe disease, a rare neuromuscular disease, virtually at the American Academy of Neurology on April 17.